These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38344294)

  • 21. Preparing for Mpox Resurgence: Surveillance Lessons From Outbreaks in Toronto, Canada.
    Sachdeva H; Shahin R; Ota S; Isabel S; Mangat CS; Stuart R; Padhi S; Chris A; Mishra S; Tan DHS; Braukmann TW; Eshaghi A; Mejia EM; Hizon NA; Finkelstein M
    J Infect Dis; 2024 Mar; 229(Supplement_2):S305-S312. PubMed ID: 38035826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How time-scale differences in asymptomatic and symptomatic transmission shape SARS-CoV-2 outbreak dynamics.
    Harris JD; Park SW; Dushoff J; Weitz JS
    Epidemics; 2023 Mar; 42():100664. PubMed ID: 36706626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological findings, estimates of the instantaneous reproduction number, and control strategies of the first Mpox outbreak in Latin America.
    Díaz-Brochero C; Cucunubá ZM
    Travel Med Infect Dis; 2024; 59():102701. PubMed ID: 38401606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of Incubation Period of Mpox during 2022 Outbreak in Pereira, Colombia.
    Estrada Alvarez JM; Acuña MH; García Arias HF; Alvarado FEP; Ospina Ramírez JJ
    Emerg Infect Dis; 2024 Jan; 30(1):180-182. PubMed ID: 38063085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral genetic clustering and transmission dynamics of the 2022 mpox outbreak in Portugal.
    Borges V; Duque MP; Martins JV; Vasconcelos P; Ferreira R; Sobral D; Pelerito A; de Carvalho IL; Núncio MS; Borrego MJ; Roemer C; Neher RA; O'Driscoll M; Rocha R; Lopo S; Neves R; Palminha P; Coelho L; Nunes A; Isidro J; Pinto M; Santos JD; Mixão V; Santos D; Duarte S; Vieira L; Martins F; Machado J; Veríssimo VC; Grau B; Peralta-Santos A; Neves J; Caldeira M; Pestana M; Fernandes C; Caria J; Pinto R; Póvoas D; Maltez F; Sá AI; Salvador MB; Teófilo E; Rocha M; Moneti V; Duque LM; E Silva FF; Baptista T; Vasconcelos J; Casanova S; Mansinho K; Alves JV; Alves J; Silva A; Alpalhão M; Brazão C; Sousa D; Filipe P; Pacheco P; Peruzzu F; de Jesus RP; Ferreira L; Mendez J; Jordão S; Duarte F; Gonçalves MJ; Pena E; Silva CN; Guimarães AR; Tavares M; Freitas G; Cordeiro R; Gomes JP
    Nat Med; 2023 Oct; 29(10):2509-2517. PubMed ID: 37696933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time Scales of Human Mpox Transmission in The Netherlands.
    Miura F; Backer JA; van Rijckevorsel G; Bavalia R; Raven S; Petrignani M; Ainslie KEC; Wallinga J;
    J Infect Dis; 2024 Mar; 229(3):800-804. PubMed ID: 37014716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysing monkeypox epidemic drivers: Policy simulation and multi-index modelling across 39 nations.
    Lin M; Xin Y; Wang J; Nie P; Yan Q; Wang L; Wang L
    J Glob Health; 2024 Feb; 14():04037. PubMed ID: 38333932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mpox Outbreak - Los Angeles County, California, May 4-August 17, 2023.
    Leonard CM; Poortinga K; Nguyen E; Karan A; Kulkarni S; Cohen R; Garrigues JM; Marutani AN; Green NM; Kim AA; Sey K; Pérez MJ
    MMWR Morb Mortal Wkly Rep; 2024 Jan; 73(2):44-48. PubMed ID: 38236779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic and epidemiological perspectives on the first local sporadic cases of Mpox in China.
    Jia H; Sha T; Zhao S; Su W; Liu P; Zhen R; Li P; Zhou L; Xu Y; Wen Y; Chi L; Di B; Li P; Chen H; Qin P
    Emerg Microbes Infect; 2023 Dec; 12(2):2245932. PubMed ID: 37542431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological clustered characteristics of coronavirus disease 2019 (COVID-19) in three phases of transmission in Jilin Province, China.
    Zhao Q; Zhang Y; Li M; Tian R; Zhao Y; Cao B; Yao L; Sheng X; Yu Y
    PLoS One; 2023; 18(1):e0279879. PubMed ID: 36656818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.
    Wu JT; Leung K; Leung GM
    Lancet; 2020 Feb; 395(10225):689-697. PubMed ID: 32014114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incubation Period and Serial Interval of Mpox in 2022 Global Outbreak Compared with Historical Estimates.
    Ponce L; Linton NM; Toh WH; Cheng HY; Thompson RN; Akhmetzhanov AR; Dushoff J
    Emerg Infect Dis; 2024 Jun; 30(6):1173-1181. PubMed ID: 38781950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Human monkeypox (Mpox)].
    Mrosik S; Rasokat H; Fabri M; Bopp L
    Dermatologie (Heidelb); 2024 Jan; 75(1):40-47. PubMed ID: 38063873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmission dynamics, complications and mitigation strategies of the current mpox outbreak: A comprehensive review with bibliometric study.
    Mohapatra RK; Singh PK; Branda F; Mishra S; Kutikuppala LVS; Suvvari TK; Kandi V; Ansari A; Desai DN; Alfaresi M; Kaabi NAA; Fares MAA; Garout M; Halwani MA; Alissa M; Rabaan AA
    Rev Med Virol; 2024 May; 34(3):e2541. PubMed ID: 38743385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: a modelling study.
    Tsang TK; Wu P; Lin Y; Lau EHY; Leung GM; Cowling BJ
    Lancet Public Health; 2020 May; 5(5):e289-e296. PubMed ID: 32330458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First, second and potential third generation spreads of the COVID-19 epidemic in mainland China: an early exploratory study incorporating location-based service data of mobile devices.
    Hu B; Qiu J; Chen H; Tao V; Wang J; Lin H
    Int J Infect Dis; 2020 Jul; 96():489-495. PubMed ID: 32425632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The time-varying transmission dynamics of COVID-19 and synchronous public health interventions in China.
    Xiao J; Hu J; He G; Liu T; Kang M; Rong Z; Lin L; Zhong H; Huang Q; Deng A; Zeng W; Tan X; Zeng S; Zhu Z; Li J; Gong D; Wan D; Chen S; Guo L; Li Y; Li Y; Sun L; Liang W; Song T; He J; Ma W
    Int J Infect Dis; 2021 Feb; 103():617-623. PubMed ID: 33181330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The study of human monkeypox disease in 2022 using the epidemic models: herd immunity and the basic reproduction number case.
    Al-Raeei M
    Ann Med Surg (Lond); 2023 Feb; 85(2):316-321. PubMed ID: 36845803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mpox patients' experience from infection to treatment and implications for prevention and control: A multicenter qualitative study in China.
    Zhang W; Qi X; Yang L; Meng X; Xu G; Luo S; Wu K; Tang J; Wang B; Fu L; Han B; He J; Zhang Y; Wang F; Lin Y; Cao W; Liu S; He L; Gao Y; Lv F; Lu H; Qian J; Zou H
    J Med Virol; 2024 Jan; 96(1):e29338. PubMed ID: 38163280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of mpox in the post-smallpox era-a narrative review on mpox epidemiology.
    Van Dijck C; Hoff NA; Mbala-Kingebeni P; Low N; Cevik M; Rimoin AW; Kindrachuk J; Liesenborghs L
    Clin Microbiol Infect; 2023 Dec; 29(12):1487-1492. PubMed ID: 37574113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.